Impact BioMedical, Inc. (IBO)
0.44
+0.02
(+6.02%)
USD |
NYAM |
Feb 20, 16:00
0.4168
-0.02
(-5.27%)
After-Hours: 20:00
Impact BioMedical EPS Diluted (Quarterly) : -0.1206 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.475M |
| Revenue (Quarterly) | 0.018M |
| Total Expenses (Quarterly) | 1.488M |
| Enterprise Value | 71.92M |
| Gross Profit Margin (Quarterly) | -1.51K% |
| Profit Margin (Quarterly) | -8.19K% |
| Earnings Yield | -854.4% |
| Normalized Earnings Yield | -322.95 |